{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:07:39Z","timestamp":1789088859514,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32300132"],"award-info":[{"award-number":["32300132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200132"],"award-info":[{"award-number":["32200132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ymthe.2025.08.051","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:40:35Z","timestamp":1756795235000},"page":"6282-6297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An alphavirus vaccine development utilizing RNA replication-defective strategy"],"prefix":"10.1016","volume":"33","author":[{"given":"Zherui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenye","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8895-3679","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.08.051_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005693","article-title":"Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas","volume":"11","author":"Forrester","year":"2017","journal-title":"Plos Negl. Trop. Dis."},{"key":"10.1016\/j.ymthe.2025.08.051_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2015.04.016","article-title":"Chikungunya: Evolutionary history and recent epidemic spread","volume":"120","author":"Weaver","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib3","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.4049\/jimmunol.1601426","article-title":"Immune-Mediated Protection and Pathogenesis of Chikungunya Virus","volume":"197","author":"Fox","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI84417","article-title":"Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies","volume":"127","author":"Silva","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.08.051_bib5","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1016\/S1473-3099(20)30491-6","article-title":"Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses","volume":"21","author":"Zaid","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.08.051_bib6","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of Chikungunya Viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"Plos Med."},{"key":"10.1016\/j.ymthe.2025.08.051_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1179\/2047773214Y.0000000163","article-title":"Dengue and chikungunya: long-distance spread and outbreaks in naive areas","volume":"108","author":"Rezza","year":"2014","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ymthe.2025.08.051_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00959","article-title":"Neurological Sequelae Resulting from Encephalitic Alphavirus Infection","volume":"7","author":"Ronca","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/vaccines8020273","article-title":"Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses","volume":"8","author":"Stromberg","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2025.08.051_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0300985810378650","article-title":"Aerobiology and Inhalation Exposure to Biological Select Agents and Toxins","volume":"47","author":"Roy","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(02)00203-6","article-title":"Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control","volume":"57","author":"Sidwell","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008876","article-title":"A molecular understanding of alphavirus entry","volume":"16","author":"Holmes","year":"2020","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.08.051_bib13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/nar\/gkab1302","article-title":"Crystal structures of alphavirus nonstructural protein 4 (nsP4) reveal an intrinsically dynamic RNA-dependent RNA polymerase fold","volume":"50","author":"Tan","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00355-21","article-title":"nsP4 Is a Major Determinant of Alphavirus Replicase Activity and Template Selectivity","volume":"95","author":"Lello","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2023.2301573","article-title":"Ixchiq (VLA1553): The first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection","volume":"15","author":"Ly","year":"2024","journal-title":"Virulence"},{"key":"10.1016\/j.ymthe.2025.08.051_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1073\/pnas.0708057105","article-title":"Generation of biologically contained Ebola viruses","volume":"105","author":"Halfmann","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.08.051_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.aivir.2021.07.003","article-title":"Alphavirus RNA replication in vertebrate cells","volume":"111","author":"Ahola","year":"2021","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008825","article-title":"Cross-utilisation of template RNAs by alphavirus replicases","volume":"16","author":"Lello","year":"2020","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2025.08.051_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2017.01.007","article-title":"Alphavirus polymerase and RNA replication","volume":"234","author":"Pietl\u00e4","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib20","article-title":"Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay","volume":"7","author":"Li","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.ymthe.2025.08.051_bib21","doi-asserted-by":"crossref","first-page":"e0136822","DOI":"10.1128\/jvi.01368-22","article-title":"Activity, Template Preference, and Compatibility of Components of RNA Replicase of Eastern Equine Encephalitis Virus","volume":"97","author":"Lello","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00720-19","article-title":"Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus","volume":"93","author":"Li","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1126\/science.aah5869","article-title":"Generation of influenza A viruses as live but replication-incompetent virus vaccines","volume":"354","author":"Si","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.08.051_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/v14071502","article-title":"Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model","volume":"14","author":"Burke","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2025.08.051_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1466252312000011","article-title":"Alphavirus replicon vaccines","volume":"13","author":"Vander Veen","year":"2012","journal-title":"Anim. Health Res. Rev."},{"key":"10.1016\/j.ymthe.2025.08.051_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3892\/ijmm.2013.1395","article-title":"Recombination of replicon and helper RNAs and the emergence of propagation-competent vectors upon Sindbis virus vector production","volume":"32","author":"Hyvarinen","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.08.051_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02494-24","article-title":"Packaging of alphavirus-based self-amplifying mRNA yields replication-competent virus through a mechanism of aberrant homologous RNA recombination","volume":"15","author":"Hick","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2025.08.051_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","article-title":"Two-helper RNA system for production of recombinant Semliki forest virus particles","volume":"73","author":"Smerdou","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105507","article-title":"Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster","volume":"209","author":"Zhang","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41422-020-00405-5","article-title":"A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles","volume":"30","author":"Zhang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41392-022-01246-x","article-title":"An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.08.051_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41392-021-00783-1","article-title":"Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.08.051_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot070581","article-title":"In vivo administration of recombinant alphavirus into rodents","volume":"2012","author":"Lundstrom","year":"2012","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.ymthe.2025.08.051_bib34","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1128\/JVI.00844-11","article-title":"Chimeric Chikungunya Viruses Are Nonpathogenic in Highly Sensitive Mouse Models but Efficiently Induce a Protective Immune Response","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.08.051_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2460\/ajvr.1977.38.04.425","article-title":"Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines","volume":"38","author":"Ferguson","year":"1977","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2025.08.051_bib36","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","article-title":"Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line","volume":"18","author":"Morgenstern","year":"1990","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625007257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:56:44Z","timestamp":1766152604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625007257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1525001625007257"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.051","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An alphavirus vaccine development utilizing RNA replication-defective strategy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}